Company Filing History:
Years Active: 2022
Title: Priyanka Narayan: Innovator in Neurodegenerative Disorder Research
Introduction
Priyanka Narayan is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in understanding neurodegenerative disorders. Her innovative work has led to the development of a patent that holds promise for treating conditions such as Alzheimer's disease.
Latest Patents
Priyanka Narayan holds a patent for "Cells expressing apolipoprotein E and uses thereof." This patent discloses yeast cells that express a polypeptide comprising a signal sequence and a human ApoE protein. The polypeptide can include variants such as ApoE2, ApoE3, and ApoE4. The patent also outlines methods for screening yeast cells to identify compounds that can prevent or suppress Apo-induced toxicity. These compounds have potential applications in treating or preventing neurodegenerative disorders, including Alzheimer's disease. Additionally, the patent describes methods for identifying genetic suppressors or enhancers of ApoE-induced toxicity.
Career Highlights
Priyanka Narayan is affiliated with the Whitehead Institute for Biomedical Research, where she conducts her research. Her work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases. With her innovative approach, she has positioned herself as a key figure in the field of biomedical research.
Collaborations
Priyanka has collaborated with notable scientists, including Susan Lindquist and Susan L. Lindquist. These collaborations have further enriched her research and contributed to advancements in the understanding of apolipoprotein E and its implications in neurodegenerative disorders.
Conclusion
Priyanka Narayan's contributions to biomedical research, particularly through her patent on apolipoprotein E, highlight her role as an innovator in the field. Her work not only advances scientific knowledge but also holds the potential for developing therapeutic strategies for neurodegenerative disorders.